ribavirin has been researched along with Acute-On-Chronic Liver Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dalton, HR; Donnelly, M; Fraser, A; Guaci, J; Gunson, R; Hussaini, SH; Kemp, L; Lin, N; Miller, M; Murray, A; Simpson, K; Spoor, J; Stanley, A; Swann, R; Wallace, SJ | 1 |
| Díaz, A; Jung, G; Lens, S; Olivas, P | 1 |
| Biliotti, E; De Angelis, M; Esvan, R; Franchi, C; Garbuglia, AR; Palazzo, D; Spaziante, M; Taliani, G; Volpicelli, L | 1 |
3 other study(ies) available for ribavirin and Acute-On-Chronic Liver Failure
| Article | Year |
|---|---|
Mortality and morbidity of locally acquired hepatitis E in the national Scottish cohort: a multicentre retrospective study.
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Aged, 80 and over; Female; Hepatitis E; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Ribavirin; Scotland | 2020 |
Hepatitis E-induced acute-on-chronic liver failure and VI nerve paralysis.
Topics: Abducens Nerve Diseases; Acute-On-Chronic Liver Failure; Aged; Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Male; Ribavirin | 2018 |
Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin.
Topics: Acute-On-Chronic Liver Failure; Biomarkers; Coinfection; Drug Therapy, Combination; Fatal Outcome; Hepatitis E; Humans; Liver Function Tests; Male; Middle Aged; Ribavirin; Shock, Septic; Sofosbuvir; Treatment Outcome; Viral Load | 2018 |